National Health Investors Inc (NHI) Stock Analysis and Metrics

National Health Investors

NYSE: NHI

$80.51 ▲ +0.56 (+0.70%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap3.86 Bn

P/E26.12

P/S9.62

Div. Yield0.00

Add ratio to table…

About

National Health Investors, Inc. is a self managed real estate investment trust established in 1991 as a Maryland corporation. The company owns leases operates and finances the development of high quality real estate properties focusing on senior housing communities and medical facilities.

The company generates revenue primarily from triple net leases with third party operators at its properties. Additionally it earns interest income from financing arrangements such as mortgages construction loans mezzanine loans and revolving lines of credit provided to tenants operators affiliates and third parties. The senior housing operating portfolio segment generates revenue from resident fees and services on each unit operated by third party managers.

The company operates through the following segments: Real Estate Investments and Senior Housing Operating Portfolio.

• The Real Estate Investments segment owns leases operates and finances the development of senior housing communities and medical facilities including independent living facilities assisted living facilities entrance fee communities senior living campuses skilled nursing facilities hospitals and provides financing arrangements such as mortgages construction loans mezzanine loans and revolving lines of credit to tenants operators affiliates and third parties.

• The Senior Housing Operating Portfolio segment consists of senior housing communities comprising independent living facilities senior living campuses and assisted living facilities located in multiple states. The company outsources operations to third party managers and pays a management fee for these services. Revenue is derived from resident fees and services on each unit.

The company competes with other REITs private equity funds healthcare providers banks and insurance companies in the acquisition leasing and financing of healthcare real estate properties. Its competitive advantages include a focus on senior housing and medical facilities a triple net lease structure that passes operating expenses to tenants and a diversified portfolio across property types and geographic regions.

The company serves triple net lease tenants who are operators of senior housing and medical facilities third party managers who operate its senior housing operating portfolio assets and borrowers who receive financing for acquisition construction or working capital needs. Specific customer names are not disclosed in the filing.

Investment Thesis

▲ Bull case

NHI's strategic pivot toward private pay senior housing is creating a structural advantage that the market is underestimating, as the company's SHOP portfolio now represents over 15% of annualized NOI and is projected to reach 24% of the total portfolio pro forma for pending dispositions, driven by newer assets with significantly better growth profiles than legacy holdings; the Colorado acquisition and other recent SHOP investments are delivering initial NOI yields of 8.3% (7.8% after CapEx), outperforming underwriting expectations and signaling that the company's redeployment of NHC sale proceeds into high-quality, healthcare-integrated senior housing assets will generate accretive returns well above the current guidance assumption of 7.8% average yield, particularly as the pipeline includes over $200 million in outstanding LOIs for larger portfolio opportunities that management has indicated are being actively negotiated with a solid chance of closing, suggesting near-term investment volume could exceed the conservative $180 million incremental investment assumption in full-year 2026 guidance.
The near-term earnings pressure from the NHC portfolio sale timing gap is being overstated by the market, as NHI has already executed reverse 1031 exchanges on over $200 million of the expected proceeds, effectively locking in tax-deferred reinvestment capacity and reducing the drag on FAD growth; with available liquidity of $960 million including $500 million ATM capacity and $391 million revolver availability, coupled with a pro forma net debt to adjusted EBITDA expected below 3x after the NHC sale, the company possesses exceptional balance sheet flexibility to accelerate redeployment into higher-yielding SHOP and triple net opportunities without relying solely on disposition proceeds, meaning the guidance-adjusted FFO per share decline of 2.9% is likely a temporary artifact of timing rather than a reflection of fundamental portfolio weakness, especially given that cash lease revenue in the triple net portfolio rose 7.7% year-over-year with no rent concessions and EBITDARM coverage improved to 1.61x for senior housing and 2.53x for medical assets excluding NHC, indicating core lease performance remains strong and resilient.
Management's cautious guidance on legacy Holiday same-store SHOP NOI growth (1%-3%) is masking the true inflection point in the SHOP platform, as the non-same-store portfolio—which includes 27 properties and represents 73% of total SHOP NOI—delivered 5.2% sequential NOI growth versus Q4 2025 and $4.3 million in NOI from just 11 transitioned and acquired properties, demonstrating that the company's recent investments are generating meaningful organic growth that is not being diluted by the legacy portfolio's underperformance; this segment's performance, driven by newer assets with healthcare components, better operator partnerships, and locations in stronger markets, supports management's expectation of high single-digit to low double-digit NOI growth for future acquisitions, implying that as the SHOP mix increases and legacy Holiday assets represent an ever-smaller portion of the platform, the portfolio's overall NOI trajectory will accelerate beyond current guidance, creating a compounding effect on FFO and FAD that is not yet priced into the stock.
The Bickford lease reset, while not highlighted as a major catalyst, represents a hidden value driver with long-term upside potential, as the new structure includes a 2%-3% annual escalator base rent of $38.4 million (up $3.2 million) and a revenue-driven conditional rent component that extends through the life of the lease, allowing NHI to participate in operator-level performance improvements; with pro forma EBITDARM coverage of 1.55x and management expressing confidence that total cash collections will increase modestly under the new structure, this asset—historically a source of volatile rent deferrals—has been transformed into a stable, growing cash flow stream with embedded optionality, reducing earnings volatility and enhancing predictability in a way that is not fully appreciated by investors focused solely on near-term SHOP transition impacts.

NHI's strategic pivot toward private pay senior housing is creating a structural advantage that the market is underestimating, as the company's SHOP portfolio now represents over 15% of annualized NOI and is projected to reach 24% of the total portfolio pro forma for pending dispositions, driven by newer assets with significantly better growth profiles than legacy holdings; the Colorado acquisition and other recent SHOP investments are delivering initial NOI yields of 8.3% (7.8% after CapEx), outperforming underwriting expectations and signaling that the company's redeployment of NHC sale proceeds into high-quality, healthcare-integrated senior housing assets will generate accretive returns well above the current guidance assumption of 7.8% average yield, particularly as the pipeline includes over $200 million in outstanding LOIs for larger portfolio opportunities that management has indicated are being actively negotiated with a solid chance of closing, suggesting near-term investment volume could exceed the conservative $180 million incremental investment assumption in full-year 2026 guidance.
The near-term earnings pressure from the NHC portfolio sale timing gap is being overstated by the market, as NHI has already executed reverse 1031 exchanges on over $200 million of the expected proceeds, effectively locking in tax-deferred reinvestment capacity and reducing the drag on FAD growth; with available liquidity of $960 million including $500 million ATM capacity and $391 million revolver availability, coupled with a pro forma net debt to adjusted EBITDA expected below 3x after the NHC sale, the company possesses exceptional balance sheet flexibility to accelerate redeployment into higher-yielding SHOP and triple net opportunities without relying solely on disposition proceeds, meaning the guidance-adjusted FFO per share decline of 2.9% is likely a temporary artifact of timing rather than a reflection of fundamental portfolio weakness, especially given that cash lease revenue in the triple net portfolio rose 7.7% year-over-year with no rent concessions and EBITDARM coverage improved to 1.61x for senior housing and 2.53x for medical assets excluding NHC, indicating core lease performance remains strong and resilient.
Management's cautious guidance on legacy Holiday same-store SHOP NOI growth (1%-3%) is masking the true inflection point in the SHOP platform, as the non-same-store portfolio—which includes 27 properties and represents 73% of total SHOP NOI—delivered 5.2% sequential NOI growth versus Q4 2025 and $4.3 million in NOI from just 11 transitioned and acquired properties, demonstrating that the company's recent investments are generating meaningful organic growth that is not being diluted by the legacy portfolio's underperformance; this segment's performance, driven by newer assets with healthcare components, better operator partnerships, and locations in stronger markets, supports management's expectation of high single-digit to low double-digit NOI growth for future acquisitions, implying that as the SHOP mix increases and legacy Holiday assets represent an ever-smaller portion of the platform, the portfolio's overall NOI trajectory will accelerate beyond current guidance, creating a compounding effect on FFO and FAD that is not yet priced into the stock.
The Bickford lease reset, while not highlighted as a major catalyst, represents a hidden value driver with long-term upside potential, as the new structure includes a 2%-3% annual escalator base rent of $38.4 million (up $3.2 million) and a revenue-driven conditional rent component that extends through the life of the lease, allowing NHI to participate in operator-level performance improvements; with pro forma EBITDARM coverage of 1.55x and management expressing confidence that total cash collections will increase modestly under the new structure, this asset—historically a source of volatile rent deferrals—has been transformed into a stable, growing cash flow stream with embedded optionality, reducing earnings volatility and enhancing predictability in a way that is not fully appreciated by investors focused solely on near-term SHOP transition impacts.

▼ Bear case

NHI's reliance on the NHC portfolio sale proceeds to fund future growth is creating substantial execution risk that the market is ignoring, as the company's guidance assumes only $180 million in incremental investments at a 7.8% average NOI yield despite having a $560 million pipeline, revealing a significant disconnect between stated opportunity and actual capital deployment plans; with CFO Spaid stating it is "not determinable" whether a special dividend will be needed and acknowledging that IRC 1031 strategies may not fully defer taxable gains, the company faces the very real prospect of having to return capital to shareholders rather than reinvest it at accretive yields, which would directly undermine the growth thesis and leave NHI with a diminished asset base and reduced earnings power after the disposition, particularly if market conditions prevent the deployment of the full $560 million in identified opportunities at the assumed yields.
The persistent underperformance of the legacy Holiday same-store SHOP portfolio, which declined 2.4% year-over-year in Q1 and now represents less than 4% of annualized NOI but continues to drag on overall SHOP performance, signals deeper operational challenges that management is underestimating, as the company attributes the issue to a "handful of properties" and CapEx delays yet has repeatedly revised downward its full-year same-store SHOP NOI guidance (now to 1%-3%) without demonstrating a credible turnaround plan, raising concerns that these assets may require significant capital infusion or face prolonged occupancy challenges due to outdated facilities, tertiary market locations, or inferior operator partnerships, meaning the drag on SHOP NOI could persist longer than anticipated and prevent the platform from achieving the high single-digit to low double-digit growth rates needed to offset dilution from increased share count and offset the earnings pressure from the NHC sale.
The company's increasing reliance on equity financing to fund growth, evidenced by a 5.8% rise in average diluted shares to 48.5 million and a 31% increase in cash G&A expenses to $5.6 million due to SHOP strategy expansion, is creating a headwind to per-share metrics that is not being adequately weighed against the growth narrative, as the dilution from equity issuances—used to avoid debt in a rising rate environment—means that even if NOI and FAD grow in absolute terms, per-share FFO and FAD growth may remain stagnant or negative, especially given that normalized FFO per share guidance is already down 2.9% year-over-year despite 4.1% FAD growth at the midpoint, indicating that the benefits of investment are being offset by share count expansion and that the market may be overestimating the accretive impact of new investments on a per-share basis without sufficient scrutiny of the capital structure trade-offs.
NHI's triple net portfolio, while showing stable cash lease revenue growth of 7.7% year-over-year, is facing a structural shift as seven properties were transitioned to SHOP during the period, and the Bickford lease reset, though favorable, introduces complexity with its revenue-driven conditional rent structure that makes future cash flows less predictable and more dependent on operator performance; with EBITDARM coverage for medical assets at 2.53x (excluding NHC) and senior housing at 1.61x, these ratios, while above distress levels, leave limited margin for error if occupancy or operating expenses deteriorate, and the company's continued focus on shifting toward SHOP—where it bears direct operational risk—may be underestimating the volatility and management intensity required in this segment, particularly as the portfolio scales and the legacy Holiday assets continue to underperform, creating a risk that the company's operational capabilities are being stretched too thin across a rapidly growing, higher-risk SHOP platform without a proportional increase in expertise or infrastructure.

NHI's reliance on the NHC portfolio sale proceeds to fund future growth is creating substantial execution risk that the market is ignoring, as the company's guidance assumes only $180 million in incremental investments at a 7.8% average NOI yield despite having a $560 million pipeline, revealing a significant disconnect between stated opportunity and actual capital deployment plans; with CFO Spaid stating it is "not determinable" whether a special dividend will be needed and acknowledging that IRC 1031 strategies may not fully defer taxable gains, the company faces the very real prospect of having to return capital to shareholders rather than reinvest it at accretive yields, which would directly undermine the growth thesis and leave NHI with a diminished asset base and reduced earnings power after the disposition, particularly if market conditions prevent the deployment of the full $560 million in identified opportunities at the assumed yields.
The persistent underperformance of the legacy Holiday same-store SHOP portfolio, which declined 2.4% year-over-year in Q1 and now represents less than 4% of annualized NOI but continues to drag on overall SHOP performance, signals deeper operational challenges that management is underestimating, as the company attributes the issue to a "handful of properties" and CapEx delays yet has repeatedly revised downward its full-year same-store SHOP NOI guidance (now to 1%-3%) without demonstrating a credible turnaround plan, raising concerns that these assets may require significant capital infusion or face prolonged occupancy challenges due to outdated facilities, tertiary market locations, or inferior operator partnerships, meaning the drag on SHOP NOI could persist longer than anticipated and prevent the platform from achieving the high single-digit to low double-digit growth rates needed to offset dilution from increased share count and offset the earnings pressure from the NHC sale.
The company's increasing reliance on equity financing to fund growth, evidenced by a 5.8% rise in average diluted shares to 48.5 million and a 31% increase in cash G&A expenses to $5.6 million due to SHOP strategy expansion, is creating a headwind to per-share metrics that is not being adequately weighed against the growth narrative, as the dilution from equity issuances—used to avoid debt in a rising rate environment—means that even if NOI and FAD grow in absolute terms, per-share FFO and FAD growth may remain stagnant or negative, especially given that normalized FFO per share guidance is already down 2.9% year-over-year despite 4.1% FAD growth at the midpoint, indicating that the benefits of investment are being offset by share count expansion and that the market may be overestimating the accretive impact of new investments on a per-share basis without sufficient scrutiny of the capital structure trade-offs.
NHI's triple net portfolio, while showing stable cash lease revenue growth of 7.7% year-over-year, is facing a structural shift as seven properties were transitioned to SHOP during the period, and the Bickford lease reset, though favorable, introduces complexity with its revenue-driven conditional rent structure that makes future cash flows less predictable and more dependent on operator performance; with EBITDARM coverage for medical assets at 2.53x (excluding NHC) and senior housing at 1.61x, these ratios, while above distress levels, leave limited margin for error if occupancy or operating expenses deteriorate, and the company's continued focus on shifting toward SHOP—where it bears direct operational risk—may be underestimating the volatility and management intensity required in this segment, particularly as the portfolio scales and the legacy Holiday assets continue to underperform, creating a risk that the company's operational capabilities are being stretched too thin across a rapidly growing, higher-risk SHOP platform without a proportional increase in expertise or infrastructure.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the REIT - Healthcare Facilities

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	WELL	Welltower Inc.	172.91 Bn	122.84	12.78	17.93 Bn
2	VTR	Ventas, Inc.	46.62 Bn	179.03	7.60	-
3	DOC	Healthpeak Properties, Inc.	15.34 Bn	69.22	-33.80	0.25 Bn
4	OHI	Omega Healthcare Investors Inc	15.14 Bn	23.22	12.25	0.43 Bn
5	AHR	American Healthcare REIT, Inc.	10.71 Bn	194.58	4.76	1.51 Bn
6	CTRE	CareTrust REIT, Inc.	9.45 Bn	28.24	199.40	0.50 Bn
7	HR	Healthcare Realty Trust Inc	7.33 Bn	-	5.04	4.10 Bn
8	SBRA	Sabra Health Care REIT, Inc.	5.09 Bn	36.93	17.13	0.04 Bn

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Segments Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password